The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Usovetskiĭ I.A.

GBOU VPO RNIMU im. N.I. Pirogova Minzdravsotsrazvitiia RF, Moskva

Sharova N.M.

Russian State Medical University, Moscow

Korotkiĭ N.G.

Rossiĭskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. N.I. Pirogova

The current view of the problem of vitiligo therapy

Authors:

Usovetskiĭ I.A., Sharova N.M., Korotkiĭ N.G.

More about the authors

Read: 106959 times


To cite this article:

Usovetskiĭ IA, Sharova NM, Korotkiĭ NG. The current view of the problem of vitiligo therapy. Russian Journal of Clinical Dermatology and Venereology. 2012;10(2):118‑123. (In Russ.)

Recommended articles:
Mechanism of action of various therapies for viti­ligo. Pharmacologist’s and dermatovenerologist’s perspective. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(6):734-741
Asse­ssment of the frequency of anti­thyroid anti­bodies carriage in patients with viti­ligo. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(6):769-776

References:

  1. Kekourou T. How to manage vitiligo in children. JEADV 2007; 23: 11-13.
  2. Baraboi V.A. Struktura, biosintez melanotsitov, ikh biologicheskaya rol', perspektivy primeneniya. Uspekhi sovrem biol 2000; 117: 86-92.
  3. Dvoryankova E.V., Tkachenko S.B. Rol' soputstvuyushchei patologii i faktorov riska v razvitii i techenii vitiligo. Klin dermatol i venerol 2006; 1: 63-65.
  4. Schallreuter K., Krueger C., Wuerfel B. et al. Childhood-vitiligo. What can we do? JEADV 2007; 31: 2: 38-41.
  5. Belkheir N.H., Duweb G.H., El-Berghath A. Vitiligo: Epidemiology and manifestations. JEADV 2008; 37: 281-288.
  6. Alkhateeb A., Fain P.R., Thody A. et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their relatives. Pigment Cell Res 2003; 16: 208-214.
  7. Liu J.B., Li V., Chen H. et al. Association of vitiligo with HLA-A2: meta-analysis. JEADV 2007; 21: 205-213.
  8. Picardo M. Non-immuological mechanisms in the pathogenesis of vitiligo: An overview. JEADV 2009; 42: 23-31.
  9. Kuz'mina T.S., Tkachenko S.B., Potekaev N.N. Vitiligo: patogeneticheskoe obosnovanie ispol'zovaniya lazera. Eksper i klin dermatokosmetol 2005; 4: 14-16.
  10. Volnukhin V.A., Proshutinskaya D.V., Vavilov A.M. i dr. Immunofenotipicheskaya kharakteristika kletochnykh infil'tratov v kozhe bol'nykh vitiligo. Vestn dermatol i venerol 2008; 3: 37-43.
  11. Antiga E., Caproni M., Del Bianco E. Analysis of TGFΒ and IL10 serum levels in patients lupus erythematodes fnd vitiligo. JEADV 2009; Suppl: SS07: 227.
  12. Njoo M.D., Bos J.D., Westerhof W. Treatment of generalized vitilitgo of children. J Am Acad Dermatol 2000; 42: 245-253.
  13. Luss L.V., Nekrasov A.V., Puchkova N.G. i dr. Rol' immunomoduliruyushchei terapii v obshcheklinicheskoi praktike. Immunologiya 2000; 5: 34-38.
  14. Khasanov D.S., Ten V.N., Vaisov A.Sh., Rakhmatov A.B. Differentsirovannye metody lecheniya bol'nykh vitiligo. Vestn dermatol i venerol 2002; 3: 32-34.
  15. Romanenko G.F., Shakhnes I.E., Barchenya V.P., Stochnik A.A. Kompleksnoe lechenie vitiligo (meladininom, vitaminami, mikroelementami, gomeopaticheskimi sredstvami) u detei i vzroslykh. Ros zhurn kozhn i ven bol 1998; 4: 42-44.
  16. Manolache L., Dumitrescu R., Benea V. Similarities in some psychosomatic aspects in alopecia areata and vitiligo patients. JEADV 2004; 18: 186-189.
  17. Kossakowska M.M., Placek W.J. Control of negative emotions and its implication for illness perception among psoriasis and vitiligo patients. JEADV 2010; 24: 4: 429-433.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.